Related Experiment Video
Updated: Dec 20, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Novel therapies for advanced urologic cancers
1Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany.
Recent advancements in urogenital cancer treatment include immunooncological therapy for renal cell carcinoma and new options for bladder, prostate, and testis cancers. These strategies are ready for routine clinical use.
Area of Science:
- Uro-oncology
- Medical oncology
- Cancer treatment
Background:
- Systemic treatment for advanced urogenital malignancies is rapidly evolving.
- Personalized treatment strategies are crucial for optimal patient outcomes.
Purpose of the Study:
- To review recently approved treatment strategies for advanced urogenital malignancies.
- To provide guidance on individualized patient treatment.
Main Methods:
- Review of recent clinical trials and therapeutic developments.
- Focus on immunooncological therapy (IOT), neoadjuvant treatments, and medical therapies for metastatic cancers.
Main Results:
- Immunooncological therapy is a primary treatment for metastatic renal cell carcinoma.
- New neoadjuvant options for muscle-invasive bladder cancer are available.
- Evolving landscape of therapies for metastatic hormone-naive and castration-resistant prostate cancer.
- Latest developments in advanced testis cancer management.
Conclusions:
- Novel treatment options are ready for routine clinical practice.
- These therapies are expected to become guideline-recommended treatments.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

